Triamcinolone Acetonide
Brand names: Kenalog-80, Triamcinolone Acetonide, Kenalog-10, Kenalog-40, Oralone, Zilretta
At a glance
- Medicare prescriptions, 2024
- 5,489,973
- Medicare drug cost
- $57.4M
- Average cost per prescription
- $10.45
- Clinicians who prescribed it
- 143,523
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Triamcinolone Acetonide Ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
From the FDA-approved prescribing information (label dated September 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Family Medicine 22.6%
- Dermatology 21.8%
- Internal Medicine 16.3%
- Nurse Practitioners 16.3%
- Physician Assistants 14.5%
- General Practice 1.1%
- Mohs Surgery 0.9%
- Geriatric Medicine 0.8%
- Podiatrists 0.7%
- OB-GYN (Obstetrics & Gynecology) 0.6%
- Allergy & Immunology 0.4%
- Dermatopathology 0.4%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 22% from 2019 to 2024.
Biggest change by state since 2019
- Delaware +39%
- Nevada +39%
- Connecticut +33%
- Virginia +33%
- Colorado +31%
- Nebraska (smallest change) +8%
- California (smallest change) +11%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 2 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
A-S Medication Solutions
| Strength | Looks like | Imprint |
|---|---|---|
| 1 mg | white cream | |
Redpharm Drug
| Strength | Looks like | Imprint |
|---|---|---|
| 1 mg | white ointment | |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
Drug makers reported $972,469 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).
- Pacira Pharmaceuticals Incorporated $849,611
- Bausch & Lomb Americas Inc. $122,857
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
4 recalls since 2020
- Sep 2023 · Eugia US LLC · Class II
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. - Aug 2022 · Padagis US LLC · Class II
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness. - Apr 2022 · McKesson Medical-Surgical Inc. Corporate Office · Class II
cGMP deviations: Temperature abuse - Mar 2021 · Cardinal Health Inc. · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.